RNAF III Becomes a Strategic Partner in ATCO Pharma to Strengthen Manufacturing and Accelerate Regional and International Expansion

The transaction establishes joint control and brings fresh growth capital to the human and animal health businesses, with Dr. Ahmed Abouelnaga continuing as CEO. Cairo, October 21, 2026 – ATCO Pharma, a leading Egyptian pharmaceutical group in human and animal health, today announced the signing of definitive agreements for RNAF III, North Africa Fund III, […]